COVID-19 is the name of a disease caused by a coronavirus and was first reported in December 2019 in Wuhan, Hubei Province, China. The World Health Organization declared COVID-19 a global pandemic in March 2020 and all EU countries and the UK are affected. How is the COVID-19 pandemic affecting people who use drugs and those who provide services to them? Has there been an impact on the drug market? This page brings together a range of resources on COVID-19 and drugs, from the EMCDDA, partner organisations and others.
What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including demand, production, trafficking and availability.Learn more